• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen.

作者信息

Chapdelaine P, Paradis G, Tremblay R R, Dubé J Y

机构信息

Hormonal Bioregulation Laboratory, Laval University Hospital Centre, Ste-Foy, Quebec, Canada.

出版信息

FEBS Lett. 1988 Aug 15;236(1):205-8. doi: 10.1016/0014-5793(88)80315-6.

DOI:10.1016/0014-5793(88)80315-6
PMID:2456954
Abstract

Using a synthetic oligonucleotide primer complementary to human prostate-specific antigen mRNA, we found that an additional sequence possibly similar to human glandular kallikrein-1 could be read by a primer-extension sequencing technique. We were able to confirm the identity of that additional sequence with another oligonucleotide primer complementary to a specific region of the human glandular kallikrein-1 mRNA sequence. Northern blot analysis with 2 oligonucleotide probes respectively specific for prostate-specific antigen and human glandular kallikrein-1 mRNAs showed that the length of both mRNAs was similar at 1.5 kb. The level of human glandular kallikrein-1 mRNA relative to that of prostate-specific antigen could be estimated as approx. 10-20%. This study constitutes the first evidence that the human glandular kallikrein-1 gene is expressed at a high level in a human tissue.

摘要

相似文献

1
High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen.
FEBS Lett. 1988 Aug 15;236(1):205-8. doi: 10.1016/0014-5793(88)80315-6.
2
cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes.编码整个人类前列腺特异性抗原的cDNA与人类组织激肽释放酶基因具有高度同源性。
Biochem Biophys Res Commun. 1989 Apr 28;160(2):903-10. doi: 10.1016/0006-291x(89)92520-5.
3
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
Biochemistry. 1992 Jan 28;31(3):818-24. doi: 10.1021/bi00118a026.
4
Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.人前列腺特异性抗原及相关hGK-1编码基因在人前列腺良恶性肿瘤中的表达
Int J Cancer. 1990 Apr 15;45(4):654-60. doi: 10.1002/ijc.2910450414.
5
Characterization of the gene for prostate-specific antigen, a human glandular kallikrein.
Biochem Biophys Res Commun. 1989 Jun 30;161(3):1151-9. doi: 10.1016/0006-291x(89)91362-4.
6
The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19.
FEBS Lett. 1989 Apr 10;247(1):123-6. doi: 10.1016/0014-5793(89)81253-0.
7
Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.雄激素可上调人前列腺特异性抗原信使核糖核酸(mRNA),但下调LNCaP细胞系中的前列腺酸性磷酸酶mRNA。
Endocrinology. 1992 Feb;130(2):766-72. doi: 10.1210/endo.130.2.1370795.
8
Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13.
Cytogenet Cell Genet. 1988;48(4):205-7. doi: 10.1159/000132629.
9
Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species.
Mol Cell Endocrinol. 1991 Apr;76(1-3):181-90. doi: 10.1016/0303-7207(91)90272-t.
10
Transcriptional regulation of prostate kallikrein-like genes by androgen.
Mol Endocrinol. 1992 May;6(5):753-62. doi: 10.1210/mend.6.5.1376410.

引用本文的文献

1
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.促性腺激素释放激素拮抗剂治疗前列腺癌后游离前列腺特异性抗原或人激肽释放酶相关肽 2 的快速消除动力学:快速监测治疗反应的潜力。
Clin Chem Lab Med. 2012 Nov;50(11):1993-8. doi: 10.1515/cclm-2011-0967.
2
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.人激肽释放酶相关肽酶3(前列腺特异性抗原)在脑中的新表达证据。
Int J Clin Exp Pathol. 2009;2(3):267-74. Epub 2008 Oct 20.
3
Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
同时定量检测前列腺癌患者外周血中人类腺体激肽释放酶2和前列腺特异性抗原的mRNA。
J Mol Diagn. 2001 Aug;3(3):111-22. doi: 10.1016/S1525-1578(10)60660-5.
4
Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.利用合成肽和计算机建模对前列腺特异性抗原(PSA)和人腺体激肽释放酶2(hK2)的抗原表位进行测定和分析。
Protein Sci. 1998 Feb;7(2):259-69. doi: 10.1002/pro.5560070205.
5
Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.免疫组织化学研究表明激肽释放酶hK2和hK3(前列腺特异性抗原)在人类前列腺肿瘤功能分析中具有互补作用。
Am J Pathol. 1997 Feb;150(2):455-9.
6
Molecular cloning, purification and in situ localization of human colon kallikrein.人结肠激肽释放酶的分子克隆、纯化及原位定位
Biochem J. 1995 Apr 15;307 ( Pt 2)(Pt 2):481-6. doi: 10.1042/bj3070481.
7
Structure, function, and regulation of the enzyme activity of prostate-specific antigen.
World J Urol. 1993;11(4):188-91. doi: 10.1007/BF00185066.
8
Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene, hGK-1.人类前列腺特异性抗原(PSA)基因:结构及其与激肽释放酶样基因hGK-1的连锁关系。
Nucleic Acids Res. 1989 Mar 11;17(5):2137. doi: 10.1093/nar/17.5.2137.
9
Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity.大鼠激肽释放酶基因家族的进化:基因转换导致功能多样性。
J Mol Evol. 1991 Jun;32(6):476-92. doi: 10.1007/BF02102650.
10
Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.人体体液中的蛋白C抑制剂。精浆富含源自整个男性生殖系统细胞的抑制剂抗原。
J Clin Invest. 1992 Apr;89(4):1094-101. doi: 10.1172/JCI115689.